#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medulloblastoma recurrent Methylmalonic acidaemia Familial amyotrophic lateral sclerosis Alport's syndrome Uveal melanoma Cardiac sarcoidosis Fibrosarcoma Small intestine adenocarcinoma Parkinson's disease Desmoplastic small round cell tumour Chronic lymphocytic leukaemia Progressive familial intrahepatic cholestasis Haematological malignancy Narcolepsy Thyroid cancer metastatic More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Treatment KBG syndrome – Trials in Disease Idiopathic inflammatory myopathy Myxofibrosarcoma – Life with Disease Basal cell naevus syndrome – Diagnostics Splenic marginal zone lymphoma – Basic Information Rhabdomyosarcoma recurrent – Life with Disease Alternating hemiplegia of childhood – Treatment CADASIL – Trials in Disease Hereditary hypophosphataemic rickets – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Losartan Potassium Tenecteplase Pitavastatin Calcium Contezolid Gedatolisib Sertraline Amantadine Hemisulfate Dabrafenib FOSMANOGEPIX Bi 3720931 BUMETANIDE Tilsotolimod Sodium Dmd06-Mab Dc-806 Duloxetine Cytisinicline Milrinone Bi 706321 Ovolecithin Varnimcabtagene Autoleucel More therapies…

    Learn about Your Condition

    Cytokine release syndrome Extraskeletal ossification Cancer fatigue Uterine leiomyoma Monogenic diabetes Angelman's syndrome Antisynthetase syndrome Lymphangiosarcoma Tinnitus Procedural hypotension Pelvic venous thrombosis Endometrial cancer stage IV Infectious pleural effusion Arthralgia Pertussis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute respiratory distress syndrome

  • Study on Premedication with Ketamine or Fentanyl for Patients with Respiratory Distress Syndrome Receiving Surfactant Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Fentanyl Citrate
    Finland

  • Study on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Pirfenidone
    • Sodium Chloride
    Italy

  • Study on Anakinra for Patients with Non-COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Anakinra
    Italy

  • Study on the Effects of Metoprolol in Patients with Acute Respiratory Distress Syndrome (ARDS)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Metoprolol Tartrate
    Spain

  • Study on FX06 for Improving Acute Respiratory Distress Syndrome in Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Glutenin
    France Germany Lithuania Romania Spain

  • Study on the Effectiveness and Safety of Reparixin for Adults with Acute Respiratory Distress Syndrome

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Reparixin
    Germany Italy
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!